Small Business Funding Opportunities

Funding Opportunities

The NINDS accepts a broad range of small business applications that are significant, innovative, and relevant to its mission. Small businesses are invited to apply for NINDS funding through the Omnibus Solicitations (PA-13-234 for SBIR; PA-13-235 for STTR) and the majority of our applications come through this general announcement. In addition, program staff will also solicit applications in specific program areas. Some specific program announcements include:

        Program Announcements

• PAR-09-220/ PAR-09-221: Innovations in Biomedical Computational Science and Technology Initiative  
• PA-11-134: Lab to Marketplace:  Tools for Brain and Behavioral Research (SBIR)
• PA-11-135: Competing Renewal Awards of SBIR Phase II Grants for Brain and Behavior Tools
• PA-11-214/PA-11-215: New Technology for Proteomics and Glycomics
• PAR-11-304/PAR-11-305: Development of Appropriate Pediatric Formulations and Drug Delivery Systems
• PA-11-347: NINDS SBIR Technology Transfer
• PAR-11-345: NeuroNEXT Small Business Innovation in Clinical Trials (U44) 
• PAR-12-054: Advanced Neural Prosthetics Research and Development (U44) 
• PAR-12-072 /PAR-12-073: NINDS Exploratory Clinical Trials for Small Business
• PAR-12-074/PAR-12-075: NINDS Competing Renewal Awards of STTR/SBIR Phase II Grants (Phase IIB) for Exploratory Clinical Trials 
• PAR-12-076/ PAR-12-077: NINDS Competing Renewal Awards of STTR/SBIR Phase II (Phase IIB) Grants 
• PA-12-149/PA-12-150: Research Supplements to Promote Diversity in Health-Related Research 
• PA-12-189/PA-12-190: Advanced Tools and Technologies for Cerebrospinal Fluid Shunts 
• PA-13-140: Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44) (note that this has new budget guidelines)
• PAR-13-090/PAR-13-191: Safe and Effective Instruments and Devices for Use in Neonatal and Pediatric Care Settings (note that this has new budget guidelines)

        Notices

• NOT-OD-13-071: HHS Reissues PHS 2013-02 SBIR and STTR Omnibus Grant Solicitations Implementing Venture Capital Provision and SBA Company Registry Requirement of the SBIR/STTR Reauthorization Act of 2011.
• NOT-NS-11-018: NINDS Policy for the Requirement of Authorization from the Food and Drug Administration (FDA) to use an Investigational Drug, Biologic Product or Device in a Clinical Trial Prior to Submission of an Application
• NOT-GM-12-108: Request for Information (RFI):  Priorities for Outsourcing of Laboratory Procedures
• NOT-OD-12-146: SBIR/STTR Niche Assessment Program for Phase I Awardees
• NOT-OD-13-003: Commercialization Assistance Program for SBIR/STTR Phase II Awardees

More details about these opportunities can be found in the NIH Guide for Grants and Contracts.